Table 2.

Distributions of MIF -173G/C genotypes in case and control group

Author	Year	Case					Control					Method	Score
		CC	CG	GG	C	G	CC	CG	GG	C	G
Arisawa T	2008	12	94	123	118	340	23	144	261	190	666	PCR-SSCPd	9
Cai KK	2013	18	43	37	79	117	6	32	42	44	116	PCR-RFLPe	8
Ding GX	2009	18	75	166	111	407	0	45	256	45	557	PCR-RFLP	8
Li HX	2012	27	101	168	155	437	12	114	193	138	500	PCR-RFLP	8
Meyer-Siegler KL	2007	/	/	/	152	110	/	/	/	57	199	PCR-sequencing	7
Ramireddy L (A)	2014	8	80	168	96	416	14	56	186	84	428	RT-PCRf	8
Ramireddy L (C)	2014	4	63	125	71	313	14	56	186	84	428	RT-PCR	8
Wu S	2011	91	117	42	299	201	39	68	40	146	148	PCR-RFLP	8
Xue Y	2010	10	108	228	128	564	13	134	369	160	872	PCR-RFLP	8
Yuan L (C)	2012	19	135	301	173	737	11	155	281	177	717	PCR-RFLP	8
Yuan L (O)	2012	1	40	89	42	218	4	61	80	69	221	PCR-RFLP	8
Yuan QB	2012	20	99	206	139	511	21	149	175	191	499	PCR-RFLP	7
Zhou SZ (GD)	2005	30	52	22	112	96	16	60	28	92	116	PCR-RFLP	8
Zhou SZ (SX)	2005	32	39	31	103	101	28	46	28	102	102	PCR-RFLP	8
Ziino O	2005	0	34	117	34	268	2	76	277	80	630	DHLPCg Wave	7

^dPolymerase chain reaction-single strand conformation polymorphism;

^ePolymerase chain reaction-restricted fragment length polymorphisms;

^fReal time-polymerase chain reaction;

^gDenaturing high performance liquid chromatography.